secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2021-12-01T23:59:59+00:00
Accession:  0001104659-21-145194
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood appoints Sravan Emany as CFO, effective Dec 6, 2021
------------------------------------------------------------

- Sravan K. Emany named SVP, CFO effective Dec 6, 2021; Jason Rickard remains COO.
- Emany previously corporate VP at Integra LifeSciences and managing director at BofA.
- Base salary $500k, bonus target 50% of base, $200k sign-on bonus, 85k RSUs and 85k PSUs.
- Emany to enter indemnification and executive severance agreement (filed as Exhibit 10.1).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/0001104659-21-145194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/tm2134154d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-145194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer